Category: Ecosystem News

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

By: Colorado BioScience Association   Date: 08/11/2021

Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood component collection, therapeutic apheresis and cellula...

Learn More

AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings

By: Colorado BioScience Association   Date: 08/06/2021

AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of a state-of-the-art commercial manufacturing...

Learn More

Boulder iQ Names Larry Blankenship as Director, Helping Life Sciences Companies with Product Development

By: Colorado BioScience Association   Date: 08/05/2021

Boulder iQ has named Larry Blankenship director. Blankenship is a veteran medical device industry professional, with more than 30 years of experience in product development, manufacturing, regulatory...

Learn More

CSU Receives $2 Million Grant to Help Prevent Future Pandemics

By: Colorado BioScience Association   Date: 07/28/2021

Building on its response to the COVID-19 pandemic, Colorado State University has received a $2 million commitment from The Anschutz Foundation to further the development of new solutions for building...

Learn More

Evergreen Research Appoints New President, Natasha Bond

By: Colorado BioScience Association   Date: 07/28/2021

Evergreen Research, Inc. (Evergreen), a leading provider of contract development, manufacturing, and regulatory/quality assurance services, is pleased to announce the appointment of Natasha (Tasha) Bo...

Learn More

Nasal-Spray Combined Vaccine for Covid and Flu Shows Protection

By: Colorado BioScience Association   Date: 07/27/2021

Vivaldi Biosciences, a clinical-stage biotechnology company developing genetically engineered intranasal vaccines for viral respiratorydiseases, today announced positive preclinical data supporting fu...

Learn More

Outlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officer

By: Colorado BioScience Association   Date: 07/27/2021

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, t...

Learn More

LightDeck Diagnostics Appoints Nick Traggis as CEO to Scale Company Operations Through Next Phase of Growth

By: Colorado BioScience Association   Date: 07/21/2021

 LightDeck Diagnostics today announced that Nick Traggis has transitioned from executive vice president of Corporate Development to Chief Executive Officer (CEO). Chris Myatt, who precedes M...

Learn More

TANOVEA® (rabacfosadine for injection) Receives Full FDA Approval as First Treatment for Lymphoma in Dogs; Elanco Acquires Product from VetDC, Inc

By: Colorado BioScience Association   Date: 07/19/2021

Elanco Animal Health Incorporated (NYSE: ELAN) announced that the  FDA has granted full approval of Tanovea for the treatment of lymphoma in dogs, making this the first conditionally approved new...

Learn More

FDA Grants First Full Approval for Treatment of Lymphoma in Dogs

By: Colorado BioScience Association   Date: 07/15/2021

Today, the U.S. Food and Drug Administration fully approved Tanovea (rabacfosadine injection) to treat lymphoma in dogs. Lymphoma, also called lymphosarcoma, is a type of cancer that can affect many s...

Learn More